National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 20645-20646 [2012-8211]
Download as PDF
<![CDATA[
20645
Federal Register / Vol. 77, No. 66 / Thursday, April 5, 2012 / Notices
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995,
Public Law 104–13), the Health
Resources and Services Administration
(HRSA) publishes periodic summaries
of proposed projects being developed
for submission to the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
To request more information on the
proposed project or to obtain a copy of
the data collection plans and draft
instruments, email paperwork@hrsa.gov
or call the HRSA Reports Clearance
Officer at (301) 443–1984.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the Agency; (b) the accuracy of the
Agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
Proposed Project: Nursing Scholarship
Program (OMB No. 0915–0301)—
[Revision]
The Nursing Scholarship Program
(NSP) is a competitive Federal program,
which awards scholarships to
individuals for attendance at accredited
schools of nursing. The Bureau of
Clinician Recruitment and Service
(BCRS) in HRSA administers the
program. The scholarship consists of
payment of tuition, fees, other
reasonable educational costs, and a
monthly support stipend. In return, the
students agree to provide a minimum of
2 years of full-time clinical service (or
an equivalent part-time commitment, as
approved by the NSP) at a health care
facility with a critical shortage of nurses
as defined by the program.
NSP recipients must be willing to
(and are required to) fulfill their NSP
service commitment at a health care
facility with a critical shortage of nurses
in the United States, which includes, in
addition to the several States, only: the
District of Columbia, Guam, the
Commonwealth of Puerto Rico, the
Northern Mariana Islands, the U.S.
Virgin Islands, American Samoa, the
Federated States of Micronesia, the
Republic of the Marshall Islands, and
Number of
respondents
Instrument
Responses
per
respondent
the Republic of Palau. Students who are
uncertain of their commitment to
provide nursing care in a health care
facility with a critical shortage of nurses
in the United States or these territories
are advised not to participate in this
program.
The NSP needs to collect data to
determine an applicant’s eligibility for
the program, to monitor a participant’s
continued enrollment in a school of
nursing, to monitor the participant’s
compliance with the NSP service
obligation, and to obtain data on its
program to ensure compliance with
statutory mandates and prepare annual
reports to Congress. The following
information will be collected: (1) From
the applicants and/or the schools—
general applicant and nursing school
data such as full name, location, tuition/
fees, and enrollment status; (2) from the
schools, on an annual basis—data
concerning tuition/fees and student
enrollment status; and (3) from the
participants and their health care
facilities with a critical shortage of
nurses, on a biannual basis—data
concerning the participant’s
employment status, work schedule and
leave usage. BCRS enters the cost
information into its information data
system, along with the projected amount
for the monthly stipend, to determine
the amount of each scholarship award.
The annual estimate of burden is as
follows:
Total
responses
Hours per
response
Total burden
hours
Application ............................................................................
In-School Monitoring ............................................................
In-Service Monitoring ...........................................................
4,000
500
600
1
1
2
4,000
500
1,200
2
2
1
8,000
1,000
1,200
Total ..............................................................................
5,100
........................
5,700
........................
10,200
Email comments to
paperwork@hrsa.gov or mail the HRSA
Reports Clearance Officer, Room 10–29,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
Tkelley on DSK3SPTVN1PROD with NOTICES
Dated: March 30, 2012.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2012–8147 Filed 4–4–12; 8:45 am]
BILLING CODE 4165–15–P
VerDate Mar<15>2010
16:20 Apr 04, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Center for HIV/AIDS
Vaccine Immunology and Immunogen
Discovery (CHAVI–ID) (UM1).
Date: April 24–27, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Rockville Executive Meeting
Center, 1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Jay Bruce Sundstrom,
Ph.D., Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
E:\FR\FM\05APN1.SGM
05APN1
20646
Federal Register / Vol. 77, No. 66 / Thursday, April 5, 2012 / Notices
6700B Rockledge Drive, MSC–7616, Room
3119, Bethesda, MD 20892–7616, 301–496–
7042, sundstromj@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreements.
Date: May 1, 2012.
Time: 1:15 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3264, Bethesda, MD 20817 (Telephone
Conference Call).
Contact Person: Lakshmi Ramachandra,
Ph.D., Scientific Review Officer, Scientific
Review Program, DEA/NIAID/NIH/DHHS,
6700–B Rockledge Drive, MSC–7616, Room
3264, Bethesda, MD 20892–7616, 301–496–
2550, Ramachandral@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: March 28, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases: Notice
of Closed Meeting
Tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Translational
Research in Diabetes and Obesity.
Date: May 17, 2012.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
16:20 Apr 04, 2012
Jkt 226001
Dated: March 28, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–8214 Filed 4–4–12; 8:45 am]
BILLING CODE 4140–01–P
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
4075, Bethesda, MD 20892, 301–402–8837,
camilla.day@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: March 28, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–8213 Filed 4–4–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Human Genome Research
Institute; Notice of Closed Meetings
[FR Doc. 2012–8211 Filed 4–4–12; 8:45 am]
VerDate Mar<15>2010
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 753, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; Loan Repayment Program.
Date: April 25, 2012.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, 3rd Floor
Conference Room, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Keith McKenney, Ph.D.,
Scientific Review Officer, NHGRI, 5635
Fishers Lane, Suite 4076, Bethesda, MD
20814, 301–594–4280,
mckenneyk@mail.nih.gov.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: April 26, 2012.
Time: 11:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Camilla E. Day, Ph.D.,
Scientific Review Officer, CIDR, National
PO 00000
Frm 00037
Fmt 4703
Sfmt 9990
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel, Program
Project Grant Review.
Date: April 25, 2012.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Eric H. Brown, MS, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy Blvd.,
Room 824, Msc 4872, (301) 594–4955,
browneri@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: March 28, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–8219 Filed 4–4–12; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 77, Number 66 (Thursday, April 5, 2012)]
[Notices]
[Pages 20645-20646]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8211]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Center for HIV/AIDS Vaccine
Immunology and Immunogen Discovery (CHAVI-ID) (UM1).
Date: April 24-27, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Rockville Executive Meeting Center, 1750 Rockville
Pike, Rockville, MD 20852.
Contact Person: Jay Bruce Sundstrom, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS,
[[Page 20646]]
6700B Rockledge Drive, MSC-7616, Room 3119, Bethesda, MD 20892-7616,
301-496-7042, sundstromj@niaid.nih.gov.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation
Cooperative Agreements.
Date: May 1, 2012.
Time: 1:15 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge 6700, 6700B
Rockledge Drive, Room 3264, Bethesda, MD 20817 (Telephone Conference
Call).
Contact Person: Lakshmi Ramachandra, Ph.D., Scientific Review
Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700-B
Rockledge Drive, MSC-7616, Room 3264, Bethesda, MD 20892-7616, 301-
496-2550, Ramachandral@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS).
Dated: March 28, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-8211 Filed 4-4-12; 8:45 am]
BILLING CODE 4140-01-P
